Did you mean : bio pharmaceuticals?
Realtime Web powered by 
All Realtime >
GlaxoSmithKline Signs $540 Million Deal for Nicotine Vaccine | Science Inc
www.fastcompany.com | Nov 16, 2009
Four years ago, the startup Nabi Biopharmaceuticals began testing a promising nicotine vaccine called NicVax with the aid of $4.1 million in funding...
First shared on Twitter by SMTrailblazer
Slashdot Science Story | Anti-Smoking Vaccine Is Nearing the Market
science.slashdot.org | Nov 20, 2009
NicVAX was developed by Nabi Biopharmaceuticals, who have agreed to license it to GlaxoSmithKline Biologicals; it is expected to complete phase III...
First shared on Twitter by artissco
http://science.slashdot.org/story/09/11/20/1853204/Anti-Smoking-Vaccine-Is-Nearing-the-Market
Slipstream - A Call to Streamline Drug Development by Sharing Information - NYTimes.com
www.nytimes.com | Nov 14, 2009
Developing new biopharmaceuticals those high-tech wonder drugs fashioned from living cells can cost $1.2 billion, according to the center.
First shared on Twitter by greenhousedoll
GlaxoSmithKline, Nabi to develop smoking vaccine
finance.yahoo.com | Nov 16, 2009
NEW YORK (AP) -- GlaxoSmithKline PLC and Nabi Biopharmaceuticals said Monday they will work together to develop vaccines to help smokers give up the...
First shared on Twitter by Nicaisse
http://finance.yahoo.com/news/GlaxoSmithKline-Nabi-to-apf-3402521489.html?.v=1
Web Results
All Web Results >
Sponsored Links
Biopharma Reference Book
All US & Euro Biopharmaceuticals New 6th Edition, 1602 Pgs Sept 2007
Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
www.bio-medicine.org | Nov 11, 2009
Keryx Biopharmaceuticals Announces Poster Presentation...MEDICINE >> TECHNOLOGY Keryx Biopharmaceuticals Announces Poster Presentation...NEW YORK Nov. 11 /- Keryx Biopharmaceuticals ...This abstract became...
Biopharmaceuticals | Industrial Customers | Boehringer Ingelheim
...Products Industrial Customers Biopharmaceuticals About us Development...Production Pharma Chemicals Biopharmaceuticals Home Industrial Customers Biopharmaceuticals The value of Partnership ...
ACCENTIA BIOPHARMACEUTICALS
it.zibb.com
Accentia Biopharmaceuticals Accentia Biopharmaceuticals® is a registered trademark used for Biologic Product...Fever, Nausea and Vomiting and owned by Accentia Biopharmaceuticals, Inc.. Full trade mark registration details...
http://it.zibb.com/trademark/accentia+biopharmaceuticals/30721719
The science of biopharmaceuticals meets business flexibility.
whitepapers.zdnet.com | Feb 20, 2008
...Blogs Videos White Papers Downloads Reviews Popular Home / White Papers The science of biopharmaceuticals meets business flexibility Topics: Collaborative Web, Resources Mgmt., ROI - TCO, Service...
Omrix Biopharmaceuticals, Inc. - Financial and Strategic Analysis Review - Market Research Reports
...Add to Basket Omrix Biopharmaceuticals, Inc. - Financial and...to a Friend Omrix Biopharmaceuticals, Inc. - Financial and...Review Summary Omrix Biopharmaceuticals, Inc. (Omrix) is...
http://www.researchandmarkets.com/reports/691531/omrix_biopharmaceuticals_inc_financial_and
ACCENTIA BIOPHARMACEUTICALS
it.zibb.com
Accentia Biopharmaceuticals Accentia Biopharmaceuticals® is a registered trademark used for Biologic Product...Fever, Nausea and Vomiting and owned by Accentia Biopharmaceuticals, Inc.. Full trade mark registration details...
http://it.zibb.com/trademark/accentia+biopharmaceuticals/30721506
Executive Development
med.monitor.com | Oct 21, 2009
...learning world. June has recently led strategic, enterprise-level projects with clients in telecommunications, biopharmaceuticals and investment banking, working in Asia, Europe and the Americas. About MONITOR EXECUTIVE DEVELOPMENT ...
Accentia Biopharmaceuticals Inc - Deals and Alliances Report
...this page print page Accentia Biopharmaceuticals Inc - Deals and Alliances Report...checkout Summary The Accentia Biopharmaceuticals Inc Deals & Alliances Report contains...information available. The Accentia Biopharmaceuticals Inc - Deals and Alliances Report...
Industry News & Blogs
All News >
Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
www.prnewswire.com | Nov 11, 2009
...Trials & Medical Discoveries Keryx Biopharmaceuticals Announces Poster Presentation...PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX...Canada and Mexico. About Keryx Biopharmaceuticals, Inc. Keryx...
Zibb.com
Zibb.co.uk
Zibb.fr
Zibbsearch.nl